KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Current Taxes: 2020-2021

Historic Current Taxes for AbCellera Biologics (ABCL) over the last 2 years, with Dec 2021 value amounting to $35.7 million.

  • AbCellera Biologics' Current Taxes rose 249.29% to $23.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $23.0 million, marking a year-over-year increase of 249.29%. This contributed to the annual value of $35.7 million for FY2021, which is 1.30% down from last year.
  • AbCellera Biologics' Current Taxes amounted to $35.7 million in FY2021, which was down 1.30% from $36.2 million recorded in FY2020.
  • AbCellera Biologics' 5-year Current Taxes high stood at $36.2 million for FY2020, and its period low was $35.7 million during FY2021.
  • Moreover, its 2-year median value for Current Taxes was $35.9 million (2020), whereas its average is $35.9 million.
  • Data for AbCellera Biologics' Current Taxes shows a maximum YoY fell of 1.30% (in 2021) over the last 5 years.
  • AbCellera Biologics' Current Taxes (Yearly) stood at $36.2 million in 2020, then decreased by 1.30% to $35.7 million in 2021.